Orlistat - Bio-X ™

CAS : 96829-58-2

Ref. 3D-BO164179

Informations sur le produit

• Nom: Orlistat - Bio-X ™
• Synonymes: N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester(-)-TetrahydrolipstatinRo 18-0647/002, (-)-Tetrahydrolipstatin, (1S)-1-{[(2R,3S)-3-hexyl-4-oxooxetan-2-yl]methyl}dodecyl N-formyl-D-leucinate, (S)-2-Formylamino-4-Methyl-Pentanoic Acid (S)-1-[[(2S,3S)-3-Hexyl-4-Oxo-2-Oxetanyl]Methyl]-Dodecyl Ester, <span class="text-smallcaps">L</span>-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester, <span class="text-smallcaps">L</span>-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester, [2S-[2α(R*),3β]]-, Listata, N-Formyl-L-Leucine (1S)-1-[[(2S,3S)-3-Hexyl-4-Oxo-2-Oxetanyl]Methyl]Dodecyl Ester, Orlipastat, Ro 18-0647/002, Ro-18-0647, Xenical, [(1S)-1-[[(2S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate
• CAS: 96829-58-2

Description

Orlistat is a drug that has been approved for the treatment of obesity. It inhibits gastric and pancreatic lipases, which are enzymes that break down dietary fats into smaller molecules to facilitate absorption. Orlistat has been shown to reduce coronary heart disease in patients with type 2 diabetes. Orlistat has also been shown to have a significant upregulation of gene expression associated with disease activity when injected into the skin of patients with primary pulmonary hypertension.
Orlistat is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 495.73 g/mol
• Formule: C₂₉H₅₃NO₅
• Couleur/Forme: Powder